- Stage IV Non-Small Cell Lung Cancer without Driver Alterations
- Published by American Society of Clinical Oncology (ASCO) on February 28, 2024
- Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations
- Published by American Society of Clinical Oncology (ASCO) on February 28, 2024
- Colorectal Cancer Screening Guidelines Toolkit
- Published by Consensus and Physician Experts (CPE) on February 27, 2024
- Breast Implant Associated Anaplastic Large Cell Lymphoma
- Published by American Society of Plastic Surgeons (ASPS) on February 27, 2024
- Immunotherapy for Inhalant Allergy
- Published by American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNS) on February 26, 2024
- Diagnosing and Treating Acute and Chronic Syndromes of the Aortic Organ
- Published by Society of Thoracic Surgeons (STS) on February 26, 2024
- Clinical Utility of Polygenic Risk Scores for Embryo Selection
- Published by American College of Medical Genetics and Genomics (ACMG) on February 23, 2024
- Principles of Analytic Validation of Immunohistochemical Assays
- Published by College of American Pathologists (CAP) on February 23, 2024
- Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases
- Published by American Gastroenterological Association (AGA) on February 21, 2024
- Management of Antineutrophil Cytoplasmic Antibody (ANCA) – Associated Vasculitis
- Published by Kidney Disease Improving Global Outcomes (KDIGO) on February 20, 2024
- Salvage Therapy for Prostate Cancer – Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy
- Published by American Society for Radiation Oncology (ASTRO); American Urological Association (AUA); Society of Urologic Oncology (SUO) on February 19, 2024
- Salvage Therapy for Prostate Cancer – Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy
- Published by American Society for Radiation Oncology (ASTRO); American Urological Association (AUA); Society of Urologic Oncology (SUO) on February 14, 2024
- Salvage Therapy for Prostate Cancer – Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions
- Published by American Society for Radiation Oncology (ASTRO); American Urological Association (AUA); Society of Urologic Oncology (SUO) on February 14, 2024
- Corneal Ectasia
- Published by American Academy of Ophthalmology (AAO) on February 12, 2024
- Corneal Edema and Opacification
- Published by American Academy of Ophthalmology (AAO) on February 12, 2024
- Conjunctivitis
- Published by American Academy of Ophthalmology (AAO) on February 12, 2024
- Adult Strabismus
- Published by American Academy of Ophthalmology (AAO) on February 12, 2024
- Blepharitis
- Published by American Academy of Ophthalmology (AAO) on February 11, 2024
- Dry Eye Syndrome
- Published by American Academy of Ophthalmology (AAO) on February 11, 2024
- Bacterial Keratitis
- Published by American Academy of Ophthalmology (AAO) on February 11, 2024
- Diagnosis and Management of Cryptococcosis
- Published by International Society for Human & Animal Mycology (ISHAM); European Confederation of Medical Mycology (ECMM) on February 9, 2024
- COVID-19 Guideline Part 4: Serologic Testing
- Published by Infectious Diseases Society of America (IDSA) on February 9, 2024
- Laboratory Recommendations for Syphilis Testing
- Published by Centers for Disease Control and Prevention (CDC) on February 8, 2024
- Imaging in Diagnosis and Management of Crystal-Induced Arthropathies in Clinical Practice
- Published by European League Against Rheumatism (EULAR) on February 6, 2024
- Use of Topical Anesthetics in the Management of Patients With Simple Corneal Abrasions
- Published by American College of Emergency Physicians (ACEP) on February 6, 2024
- Follow-up and Surveillance of Curatively Treated Lung Cancer Patients
- Published by Cancer Care Ontario (CCO) on February 4, 2024
- Clinical Management of Diphtheria
- Published by World Health Organization (WHO) on February 2, 2024
- Guidelines for Specialized Epilepsy Centers
- Published by National Association of Epilepsy Centers (NAES) on February 2, 2024
- Permanent Contraception: Ethical Issues and Considerations
- Published by American College of Obstetricians and Gynecologists (ACOG) on February 1, 2024
- Influenza in Pregnancy: Prevention and Treatment
- Published by American College of Obstetricians and Gynecologists (ACOG) on February 1, 2024
- Persistent, Post-adenotonsillectomy Obstructive Sleep Apnea in Children
- Published by American Thoracic Society (ATS) on February 1, 2024
- Optimizing Radiation Safety in Dentistry
- Published by American Dental Association on February 1, 2024
- Targeted Neonatal Echocardiography and Cardiac Point-of-Care Ultrasound in the Neonatal Intensive Care Unit
- Published by American Society of Echocardiography (ASECHO) on February 1, 2024
- Performing a Comprehensive Pediatric Transthoracic Echocardiogram
- Published by American Society of Echocardiography (ASECHO) on February 1, 2024
- Prevention of Breast Cancer-Related Arm Lymphoedema (BCRAL)
- Published by Multinational Association of Supportive Care in Cancer (MASCC) on February 1, 2024
- Imbruvica (Janssen)New Formulation
- Oral suspension formulation for adult patients in the treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
- Exblifep (Allecra Therapeutics)
- Treatment for complicated urinary tract infections (cUTIs), including pyelonephritis, in patients 18 years and older.
- Biktarvy (Gilead)Expanded Indication
- To treat people with HIV (PWH) who have suppressed viral loads with known or suspected M184V/I resistance.
- Simlandi (Teva / Alvotech)Biosimilar to Humira
- Interchangeable biosimilar to Humira, for the treatment of adult rheumatoid arthritis, juvenile idiopathic arthritis, adult psoriatic arthritis, adult ankylosing spondylitis, Crohn’s disease, adult ulcerative colitis, adult plaque psoriasis, adult hidradenitis suppurativa and adult uveitis.
- Tagrisso (AstraZeneca)New Indication
- Treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC).
- Xolair (Novartis / Genentech) New Indication
- For reducing allergic reactions to foods in adults and most children. The drug is meant to be taken regularly by patients with food allergies to reduce the risk for reactions, including anaphylaxis, in case of accidental exposure to one or more allergens.
- Amtagvi (Iovance Biotherapeutics)
- Treatment of certain adults with unresectable or metastatic melanoma.
- Aurlumyn (Actelion Pharmaceuticals)
- To treat severe frostbite in adults to reduce the risk of finger or toe amputation.
- Onivyde (Ipsen)New Indication
- First-line treatment in adults living with metastatic pancreatic adenocarcinoma (mPDAC).
- Eohilia (Takeda)
- For people 11 years and older with eosinophilic esophagitis (EoE).
Copyright © 2024 Guideline Central, All rights reserved.